Back
BridgeBio Pharma, Inc. Vs. BlueLinx Holdings, Inc. Industry Stock Comparison
Sell
48
BBIO
BridgeBio Pharma, Inc.
Last Price:
$76.56
Seasonality Move:
-6.92%
Buy
56
BXC
BlueLinx Holdings, Inc.
Last Price:
$62.39
Seasonality Move:
18.73%
Sell
48
BridgeBio Pharma, Inc. (BBIO)
is a Sell
Is BridgeBio Pharma, Inc. a Buy, Sell or Hold?
-
The current BridgeBio Pharma, Inc. [BBIO] share price is $76.53. The Score for BBIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
BlueLinx Holdings, Inc. (BXC)
is a Buy
Is BlueLinx Holdings, Inc. a Buy, Sell or Hold?
-
The current BlueLinx Holdings, Inc. [BXC] share price is $62.46. The Score for BXC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BBIO Stock Price Chart
What is BridgeBio Pharma, Inc.'s stock price today?
-
The BridgeBio Pharma, Inc. share price today is $76.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BXC Stock Price Chart
What is BlueLinx Holdings, Inc.'s stock price today?
-
The BlueLinx Holdings, Inc. share price today is $62.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BXC is experiencing buying pressure, which is a positive indicator for future bullish movement.
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.65 | Buy |
| Relative Strength Index (14 RSI): | 65.5 | Buy |
| Chaikin Money Flow: | -368631 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.76 - 76) | Buy |
| Bollinger Bands (100): | (49.72 - 68.66) | Buy |
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 50.05 | Buy |
| Chaikin Money Flow: | 22434 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.59 - 64.53) | Buy |
| Bollinger Bands (100): | (61.75 - 78.81) | Sell |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.59 | Buy |
| 20-day SMA: | 74.1 | Buy |
| 50-day SMA: | 67.02 | Buy |
| 200-day SMA: | 48.78 | Buy |
| 8-day EMA: | 75.67 | Buy |
| 20-day EMA: | 73.55 | Buy |
| 50-day EMA: | 67.93 | Buy |
| 200-day EMA: | 52.27 | Buy |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.36 | Sell |
| 20-day SMA: | 62.54 | Sell |
| 50-day SMA: | 63.45 | Sell |
| 200-day SMA: | 71.99 | Sell |
| 8-day EMA: | 62.78 | Sell |
| 20-day EMA: | 62.4 | Buy |
| 50-day EMA: | 64.18 | Sell |
| 200-day EMA: | 74.48 | Sell |
BridgeBio Pharma, Inc. Earnings Growth & BBIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $1.42 per share.
BlueLinx Holdings, Inc. Earnings Growth & BXC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.29 per share, and an increase next year of $0.86 per share.
BridgeBio Pharma, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BlueLinx Holdings, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||